Posts

MindMed's Phase 2 LSD Trial Treating Anxiety Was a SuccessShutterstock

MindMed’s Phase 2 LSD Trial Treating Anxiety Was a Success

, ,
Researchers at PSYCH Symposium reveal promising results from double-blind, placebo-controlled study with 46 patients.
Why Wednesday Will Be Biggest Day for Psychedelic Investors of 2022Shutterstock

Why Wednesday Will Be Biggest Day of 2022 for Psychedelic Investors

,
Psychedelic investors are about to see pivotal data presented on flagship programs by the titans of the psychedelics industry.